S
epsis is a common and serious complication in diabetic patients, and is a well-recognized cause of mortality (1, 2) . Mice given experimental diabetes are more susceptible to a variety of bacterial infections, including Klebsiella pneumoniae (3), Listeria monocytogenes (4), Streptococcus sp. (5) , and Mycobacterium tuberculosis (6) . Despite these considerations, little is known about the immunological mechanisms that confer the increased susceptibility to infection observed during diabetes (7, 8) . Deficiencies in leukocyte functions have been described in experimental and clinical diabetes, including reduced migration (9) , chemotaxis (10), phagocytosis (11) , and microbicidal activity (12) . We and others have shown that the severity of sepsis in nondiabetic mice and patients is associated with reduced neutrophil migration to the focus of infection. This reduction in neutrophil migration is due to the internalization of the chemokine receptor CXCR2 and modulation of adhesion molecules expression on endothelium (13) (14) (15) . CXCR2 internalization is associated with upregulation of G protein-coupled receptor kinase 2 (GRK2) expression in circulating neutrophils, which is, at least partially, mediated by systemic TLR2 and TLR4 activation (16) (17) (18) .
Invading microorganisms are recognized via pattern recognition molecules such as TLRs by resident cells, including mast cells (MCs) and macrophages (19) . TLR2 and TLR4 signaling triggers a local inflammatory response through cytokine production and MC degranulation (20) . MC-deficient mice (W/W v ) are more susceptible to peritonitis induced by either cecal ligation and puncture (CLP) or Klebsiella pneumonia infection, and this susceptibility can be suppressed by improving the local inflammatory response by transferring MCs into the peritoneal cavity (21, 22) . On the other hand, systemic release of cytokines by MCs impairs neutrophil migration to the focus of infection and can lead to death during sepsis (23, 24) .
Histamine, a major component of MC granules, binds to four receptor subtypes, histamine H 1 receptor (H 1 ) to H 4 . Neutrophils have been shown to express both H 1 and H 2 (25, 26) , and H 2 signaling mediates the inhibition of neutrophil chemotaxis (27) . In addition, histamine signaling via H 2 negatively regulates human neutrophil activation, superoxide production, degranulation, and 5-lipoxygenase-derived leukotriene B 4 (LTB 4 ) synthesis (28) (29) (30) . In the CLP model, 5-lipoxygenase-null mice with severe sepsis (SS) presented a reduction in neutrophil migration and increase of bacterial load in the focus of infection (31) . Collectively, these findings imply that histamine could inhibit the LTB 4 production and dampen the neutrophil migration.
It was demonstrated that histamine levels are increased in plasma and tissues in diabetic rats, as well as in patients with diabetes mellitus (32, 33) . Moreover, levels of histamine are higher in diabetic rats than in nondiabetic animals after LPS administration (34) . In agreement, in this study, we found that histamine is increased in diabetic mice undergoing septic peritonitis. Moreover, we observed that histamine released by MCs decreases neutrophil migration to the infection site through interaction with H 2 , resulting in impaired host defense and a poor sepsis outcome in diabetic mice. 
Materials and Methods

Mice
Diabetes induction
Diabetes was induced with a single i.v. injection of alloxan (Sigma Chemical Company, St. Louis, MO) at a dosage of 50 mg/kg in saline (100 ml). The nondiabetic control group received an i.v. injection of saline alone. Blood samples were collected from the tail vein to measure blood glucose levels using a glucometer (Precision Xtra Abbott, Alameda, CA).
Sepsis model
Sepsis was induced by CLP as previously described (36) . In brief, mice were anesthetized with ketamine (100 mg/kg) and xylazine (10 mg/kg) by i.p. injection. A 1-cm midline incision was made on the anterior abdomen, and the cecum was exposed and ligated below the ileocecal junction without causing bowel obstruction. A single puncture was made in the cecum using an 18-gauge needle to induce SS, or three punctures were made using a 30-gauge needle to induce mild sepsis (MS). The cecum was squeezed to express its contents through the puncture holes and then placed back into the abdominal cavity. The peritoneal wall and skin incisions were closed. Sham-operated (Sham) animals were submitted to laparotomy but without punctures in cecum.
Pharmacological treatment
Nondiabetic mice were treated s.c. with histamine (3 mg or 10 mg in 100 ml saline) (Sigma Chemical Company, St. Louis, MO), 1 h before CLP and every 24 h afterward for a total of 5 d for survival rate analysis, or treated 1 h before CLP with 10 mg histamine per mouse for neutrophil migration, bacterial load, and CXCR2 expression evaluation. Ten days after alloxan treatment, diabetic mice were injected i.p. with pyrilamine (20 mg/kg, a selective H 1 antagonist), cimetidine (20 mg/kg, a selective H 2 antagonist), thioperamide (5 mg/kg, an H 3/4 antagonist), or saline 1 h before CLP and every 24 h afterward for a total of 5 d for the survival rate analysis. Compound 48/80 (C48/80; Sigma Chemical Company) was administered two times per day for 4 d i.p. at dosages of 0.6, 1.0, 1.2, or 2.4 mg/kg before CLP. Ten days after saline or alloxan administration, diabetic and nondiabetic mice underwent MS induction, SS induction, or a sham operation as the control according to the CLP model (Supplemental Fig. 1A ).
Neutrophil migration to the peritoneal cavity
Peritoneal cavity lavage (PCL) was performed after 4 or 6 h of sepsis induction using 3 ml PBS/EDTA 1 mM. Total cell counts were obtained using a cell counter (Coulter Analyzer; Coulter), and differential cell counting was conducted using cytocentrifuge slides (Shandon Southern Products) stained with May-Grunwald-Giemsa.
Bacterial count
Four or 6 h after CLP, the blood was collected and the peritoneal cavity was washed with 1.5 ml sterile PBS/EDTA. Aliquots of serial dilutions of these samples were placed on Muller-Hinton agar dishes (Difco Laboratories) and incubated at 37˚C. CFUs were analyzed after 18 h, and the results were expressed as log of CFU/10 ml.
GRK2 immunofluorescence
Immunofluorescence was used to analyze GRK2 expression on blood neutrophils at 6 h postsurgery using anti-mouse GRK2 (Y137; Abcam) as the primary Ab, as previously described (14) . Cell nuclei were stained with DAPI. Fluorescent images were analyzed using an Olympus BX-50 epifluorescence microscope.
Flow cytometry
One hundred microliters of blood was stained using PerCP-Cy5.5-conjugated anti-mouse myeloid lineage differentiation Ag Gr-1 (GR-1) (BD Bioscience, Franklin Lakes, NJ), PE-conjugated anti-CXCR2 mAb (R&D Systems, Minneapolis, MN), or the appropriate isotype controls. The cells were washed, fixed in 2% formaldehyde, and analyzed by flow cytometry in a FACSort flow cytometer using CellQuest software. Neutrophils were identified by their light scatter properties and high GR-1 expression. MC number was determined using double staining with PECy5-conjugated anti-CD117 and FITC-conjugated anti-FcεRI (eBioscience, San Diego, CA). The GRK2 staining was evaluated by flow cytometry in neutrophils as previously described (37) .
Detection of serum TNF-a and CXCL-2 levels TNF-a and CXCL-2 levels were assessed in serum and PCL 6 h after surgery by ELISA. The results were displayed in picograms per milliliter as the mean 6 SEM.
Histamine measurement
Mouse plasma histamine concentration was measured 6 h after surgery using an immunoenzymatic method with a manufactured kit (Cayman, Ann Arbor, MI).
Neutrophil isolation and chemotaxis assay
Bone marrow or blood neutrophils were isolated using a Percoll gradient as described previously (14) . Neutrophil suspensions were incubated with RPMI 1640 (Sigma-Aldrich) or histamine at a concentration of 1 or 10 mM for 1 h, and neutrophil chemotaxis was assessed toward CXCL-2 (30 ng/ ml; R&D Systems, Minneapolis, MN) in a Boyden chamber (Neuro Probe, Bethesda, MD). In another set of experiments, the chemotactic activity of blood neutrophils obtained from related experimental groups was assessed for CXCL-2 (30 ng/ml), fMLF (10 27 M), or RPMI 1640 (negative control).
Vascular leakage
Evans blue dye (2.5% in 100 ml of PBS) was i.v. administered 30 min before CLP. Two hours after CLP, the mice were killed, and the peritoneal cavity was washed with 1.5 ml PBS/EDTA (1 mM). The cells were spun down, and the OD of the supernatant at 600 nm was measured. The concentration of Evans blue in peritoneal exudates was determined under a standard curve.
Determination of the myeloperoxidase activity
The extent of leukocyte accumulation in the lung was measured by myeloperoxidase assay as previously described (38) . The absorbance of the tissue supernatant was compared with a standard curve of mouse peritoneal neutrophils, and the results were reported as the mean 6 SEM of the total number of neutrophils per milligram of lung.
Statistical analysis
The log-rank test was used to evaluate the survival rate, and the proportional risk model of Cox was used to identify the differences between groups. The Mann-Whitney U test was used to assess the following variables: blood and PCL bacterial count between vehicle-administered MS group versus histamine-administered MS group and d body weight. The one-way ANOVA, followed by Tukey's multiple-comparison test, was used for the others variables. A p value , 0.05 was considered statistically significant.
Results
Diabetic mice showed increased MC numbers after MS
Alloxan-induced diabetes is a common experimental model used to study the pathophysiologic mechanisms involved in type 1 diabetes (39) . Blood glucose levels in diabetic mice were increased 10 d after alloxan administration (Supplemental Fig. 1B ), and these mice showed reduced body weight compared with nondiabetic mice (Supplemental Fig. 1C ). We also evaluated the numbers of MCs (FcεRI + /CD117 + cells) in the peritoneal cavity during diabetes by flow cytometry. Interestingly, we observed higher numbers of MCs in the peritoneal cavity of sham-operated (sham) diabetic mice compared with sham nondiabetic mice. In addition, diabetic mice had a significant increase in MCs in their peritoneal cavity compared with nondiabetic mice after MS induction. However, the number of MCs in MS diabetic mice did not differ from sham diabetic mice (Fig. 1A) . We also observed a significant increase in the MC numbers in the peritoneal cavity of naive diabetic mice that did not undergo sham surgery compared with related nondiabetic mice (Supplemental Fig. 1D ).
MC degranulation contributes to sepsis onset in diabetic mice
To evaluate the role of MCs in diabetic mice given sepsis, we pretreated diabetic mice with C48/80, an agent that induces MCgranule depletion (40) , for 4 d before MS induction. Diabetic mice exhibited 100% mortality rate after MS, whereas all nondiabetic mice survived for 5 d after surgery (Fig. 1B) . C48/80 pretreatment of diabetic mice enhanced survival rate to 42% after MS induction. As a control for sepsis induction, we induced SS in nondiabetic mice and observed that they died within 3 d after surgery (Fig. 1B) . The nondiabetic mice pretreated with C48/80 had a 33.3% survival rate after SS, whereas all SS mice that were not pretreated with C48/80 died. The survival rates of the pretreated mice and nonpretreated mice after MS were 85.7 and 100%, respectively, demonstrating that the pretreatment with C48/80 did not alter the MS survival rate (Supplemental Fig. 2D ). It is important to mention that the pretreatment of diabetic mice with C48/ 80 had no effect on blood glucose levels or weight loss (Supplemental Fig. 1B, 1C) .
We next examined the end points commonly associated with survival in the CLP model, including neutrophil migration to the focus of infection and the bacterial load 6 h after surgery. MS diabetic mice, which were more susceptible to sepsis, lost their ability to control infection, as demonstrated by a higher bacterial load in the peritoneal cavity and blood than MS nondiabetic mice (Fig. 1C, 1D ). Mice undergoing SS also had a higher CFU content in these compartments compared with MS nondiabetic mice. Similar to our observations of survival rate, pretreatment of diabetic mice with C48/80 significantly decreased the CFU content in the peritoneal cavity and the blood of the MS diabetic mice (Fig.  1C, 1D ). MS nondiabetic mice showed a significant increase in neutrophil migration to the peritoneal cavity compared with sham nondiabetic mice (Fig. 1E) . In contrast, MS diabetic mice had decreased neutrophil migration in the peritoneal cavity, which were similar to the numbers observed in SS nondiabetic mice. Notably, pretreatment of diabetic mice with C48/80 significantly prevented the impaired neutrophil migration toward the focus of infection (Fig. 1E) . Similarly, the directional migration (chemotaxis) toward CXCL-2 was significantly increased in these pretreated mice compared with MS nontreated diabetic mice (Fig. 1F) . We also observed that the pretreatment with C48/80 of diabetic mice restored the random migration (chemokinesis) of blood neutrophils compared with nontreated diabetic mice after MS induction (Fig. 1F) .
High systemic levels of proinflammatory cytokines and leukocyte sequestration in the lungs correlate with sepsis severity (41) . Accordingly, we found higher levels of leukocytes in the lungs of diabetic MS mice and nondiabetic SS mice than in nondiabetic MS mice. Pretreatment of diabetic mice with C48/80 attenuated this leukocyte infiltration into the lungs after MS induction (Supplemental Fig. 2A ). In addition, diabetic MS mice exhibited higher serum concentrations of TNF-a and CXCL-2 than nondi-FIGURE 1. MC granule depletion induces septic peritonitis control in diabetic mice. MC numbers were quantified in the peritoneal cavity using MCspecific markers (CD117 and FcεRI) in nondiabetic or diabetic mice 10 d after alloxan administration (A). Nondiabetic mice and diabetic mice were pretreated with saline or C48/80 before induction of MS. SS was carried out in nondiabetic mice. The survival rates were evaluated daily for 5 d after CLP surgery (B). Bacterial burden in the PCL (C), blood (D), and neutrophil numbers (E) into the peritoneal cavity was quantified 6 h after surgery. Blood neutrophils were obtained from sham-operated, nondiabetic (ND), and diabetic mice pretreated with saline or C48/80 after MS surgery. The chemotactic activity of blood neutrophils toward CXCL-2 (30 ng/ml) or RPMI 1640 (negative control) was determined in Boyden chambers (F). The results were expressed as the mean 6 SEM (n = 5-7). These are representative graphs of at least two independent experiments. *p # 0.05 compared with the nondiabetic sham-operated group, abetic MS mice, which were reduced significantly by C48/80 pretreatment (Supplemental Fig. 2B, 2C ).
MC degranulation promotes GRK2 upregulation and CXCR2 downregulation in neutrophils
Reduced neutrophil migration to focus of infection can result from GRK2-mediated downregulation of CXCR2 in circulating neutrophils (16) . To address this possibility, we analyzed CXCR2 expression by flow cytometry and GRK2 by immunofluorescence in circulating neutrophils after MS in alloxan-induced diabetic and nondiabetic mice. As shown in Fig. 2A , circulating neutrophils from MS diabetic mice exhibited a significant reduction in CXCR2 expression compared with those from both sham (nondiabetic and diabetic) and MS nondiabetic mice. Pretreatment of diabetic mice with C48/80 significantly prevented the CXCR2 downregulation in MS diabetic mice. Moreover, we observed that GRK2 protein expression was increased in neutrophils from MS diabetic mice and SS nondiabetic mice compared with the MS nondiabetic or shamoperated groups. The pretreatment of diabetic mice with C48/80 prevented this increased GRK2 expression (Fig. 2C) . Our results also demonstrated that neutrophils from SS mice presented higher GRK2 expression compared with sham-operated nondiabetic mice. In addition, pretreatment with C48/80 prevented GRK2 induction in the neutrophils from these mice (Supplemental Fig. 2E ).
H 2 antagonist treatment alleviates sepsis in diabetic mice
As shown in Fig. 2B , MS diabetic mice produced higher levels of histamine compared with both sham (nondiabetic and diabetic) and MS nondiabetic mice. As previously shown (Fig. 1B) , depleting MC granules with C48/80 decreased the severity of sepsis in diabetic mice after MS induction. This pharmacologic intervention also significantly decreased serum histamine levels in MS diabetic mice (Fig. 2B) . This finding suggested that the high serum levels of histamine in diabetic mice may contribute to poor sepsis outcome. To test this hypothesis, we used histamine receptor antagonists in diabetic mice given MS. Treatment with an H 1 antagonist (pyrilamine) delayed the death of the mice, but all mice still died within 4 d of MS induction (Fig. 3A) . In contrast, treating diabetic mice with an H 2 antagonist (cimetidine) increased the survival rate by ∼45%. The treatment of MS diabetic mice with an H 3/4 antagonist (thioperamide) did not influence their survival rate (Fig. 3A) . As shown in Fig. 3B , the combination of H 1 and H 2 antagonists had no effect on survival rates of diabetic mice after MS induction.
We next evaluated the effects of the H 2 antagonist on neutrophil recruitment to the focus of infection, blood bacterial load, and CXCR2 expression in circulating neutrophils in MS diabetic mice. H 2 blockade significantly restored the neutrophil migration to the peritoneal cavity of MS diabetic mice (Fig. 3C ), resulting in a significantly lower bacterial load in the blood compared with nontreated MS diabetic mice (Fig. 3D ). In addition, treatment with the H 2 antagonist increased CXCR2 expression in the neutrophils of the MS diabetic mice (Fig. 3E ). Blood neutrophils from the MS diabetic mice have a reduced chemotactic response to CXCL-2, but not to fMLF, compared with the MS nondiabetic mice, excluding the possibility of cross desensitization for this receptor. In FIGURE 2. MC granule depletion prevents CXCR2 internalization and histamine release during polymicrobial peritonitis in diabetic mice. Quantitative analysis of the mean intensity of fluorescence (MFI) for CXCR2 in blood cells with high expression of GR-1 (neutrophils) was evaluated by flow cytometry (A). Serum histamine levels were determined 6 h after surgery from several experimental groups as described earlier (B). Blue staining by DAPI represents neutrophil nuclei; red staining represents GRK2 expression in neutrophil cytoplasm (C) (original magnification 3400). An overlay of nuclei and GRK2 expression shows the qualitative analysis from several experimental groups. Results are expressed as the mean 6 SEM (n = 5-7). These are representative graphs of at least two independent experiments. *p # 0.05 compared with the nondiabetic sham-operated group, # p # 0.05 compared with the nondiabetic MS group, addition, H 2 pretreatment of the MS diabetic mice significantly restored the chemotactic response to CXCL-2, compared with the chemotactic response of the blood neutrophils of the MS diabetic nontreated mice (Supplemental Fig. 3A) .
To determine whether these observations in MS diabetic mice were attributable to differences in vascular permeability between the septic groups, we used Evans blue extravasation in the peritoneal cavity as an index for vascular leakage. The Evans blue content during the first 2 h after MS was prominently increased in both the nondiabetic and diabetic mice compared with nondiabetic sham-operated mice. H 2 antagonist treatment did not alter the Evans blue content in the peritoneal cavity of the MS diabetic mice (Fig. 3F) .
Histamine is involved in septic peritonitis susceptibility
Our earlier results suggested that histamine negatively regulated neutrophil migration. To test this hypothesis, we first incubated neutrophils with histamine (1 and 10 mM) and observed a reduction in their chemotactic response to CXCL-2 (Fig. 4A) . Accordingly, neutrophil incubation with histamine (10 mM) also promoted CXCR2 internalization (Fig. 4B) . Pretreatment of >neutrophils with an H 2 antagonist significantly prevented the histamine-induced CXCR2 downregulation (Fig. 4B) . In addition, neutrophils incubated with histamine showed increased intracellular GRK2 expression compared with neutrophils incubated with RPMI (control). However, preincubation of neutrophils with an H 2 antagonist significantly diminished the histamine-induced upregulation of GRK2 expression (Supplemental Fig. 3B, 3C) .
Enhanced infiltration of neutrophils into the inflammatory site was observed in air-pouch inflammation (42) and bacterial peritonitis (43) in histidine decarboxylase-deficient mice, which cannot produce histamine, indicates that histamine inhibits neutrophil recruitment. Thus, we examined the role of histamine in neutrophil recruitment in the septic peritonitis model. In vivo, administration of 3 or 10 mg histamine per mouse decreased the survival rates by ∼30 and 50%, respectively, 5 d after MS surgery (Fig. 4C) . Histamine administration also significantly inhibited neutrophil migration to the focus of infection, resulting in impaired infection control as shown by reduced bacterial clearance in the peritoneal cavity and an enhanced bacterial load in the blood (Fig. 4D, 4E) . Moreover, systemic histamine administration significantly reduced the CXCR2 expression in the blood neutrophils in MS mice (Fig. 4F) . Moreover, the H 2 antagonist treatment significantly prevented the downregulation of CXCR2 expression in neutrophils from mice given MS (Fig. 4F) .
MC deficiency protects diabetic mice from SS
Next, we evaluated sepsis progression in mice lacking MCs (W/W v ) and their littermate controls (WB/B6). Our results showed that nondiabetic W/W v mice were more susceptible to MS than control WB/B6 nondiabetic mice (Fig. 5A ). We observed a significant decrease in neutrophil numbers in the peritoneal cavity accompanied by increased bacterial load at the focus of infection and in the blood of MS W/W v nondiabetic mice compared with MS WB/ B6 nondiabetic mice (Fig. 5B-D) . In contrast, diabetic W/W v mice with MS showed ∼25% improvement in the survival rate compared with WB/B6 diabetic mice with MS (Fig. 5A) . In parallel, we observed that diabetic WB/B6 mice given MS had a significant reduction in neutrophil migration and increased peri- toneal cavity and blood bacterial loads compared with nondiabetic WB/B6 MS mice. In contrast, diabetic W/W v mice displayed higher neutrophil numbers and reduced bacterial loads in the peritoneal cavity and blood compared with diabetic WB/B6 mice after the MS induction (Fig. 5B-D) . Analysis of blood neutrophils by flow cytometry showed that MC deficiency did not affect CXCR2 expression on neutrophils from nondiabetic mice with MS, but prevented CXCR2 downregulation on neutrophils after MS induction in diabetic mice (Fig. 5E ).
H 2 antagonist treatment improves infection control in NOD mice
Finally, we used NOD mice, which spontaneously develop type 1 diabetes, to confirm the role of H 2 in sepsis pathogenesis in diabetic mice. We first observed a significant increase in MC numbers (FcεRI + /CD117 + cells) in the peritoneal cavity of NOD mice after MS induction compared with sham-operated prediabetic mice (Fig. 6A) . Our results also revealed elevated serum histamine concentrations in these mice (Fig. 6B) . We also observed that 25% of prediabetic NOD mice died after MS surgery, but the mortality rate increased to 50% in MS NOD mice. In addition, the H 2 antagonist abrogated the mortality rate in NOD mice undergoing MS (Fig. 6C) . Furthermore, neutrophil migration to the peritoneal cavity was impaired, and the blood and peritoneal bacterial loads were increased in NOD mice compared with prediabetic NOD mice after MS induction (Fig. 6D, 6E) . However, we noted a significant increase in neutrophil migration to the focus of infection and reduced bacterial loads in the blood and peritoneal cavity when NOD mice were pretreated with the H 2 antagonist (Fig. 6D,  6E) . In vivo, H 2 antagonist pretreatment of NOD mice also prevented downregulation of CXCR2 in blood neutrophils and the impaired chemotactic response to CXCL-2 exhibited by these cells of MS NOD mice (Supplemental Fig. 4A, 4B ).
Discussion
The factors that determine whether a particular infection in a diabetic mouse or patient will be successfully controlled or progress to sepsis are not well understood. Neutrophils from diabetic mice without any apparent infections already have functional abnormalities, including decreased phagocytic capacity (44) and chemotactic responses (45) . In addition, increased numbers of tissue MCs have been found in clinical diabetes (46) . Studies using experimental models also demonstrated that MCs are more abundant in different tissues of diabetic rats compared with related nondiabetic rats (47) . Consistent with these findings, we observed that the increase in peritoneal MC numbers in diabetic mice coincided with the severity of sepsis and impaired neutrophil migration during septic peritonitis.
Based on these results, we evaluated the role of MCs in the increased sepsis susceptibility of diabetic mice using several approaches. Pretreatment of diabetic mice with C48/80 induced marked neutrophil migration to the focus of infection, which was associated with decreased bacteremia and an improvement in the survival rate after MS. In agreement, we observed that the high TNF-a and CXCL-2 levels in the serum of diabetic mice undergoing septic peritonitis were decreased by C48/80 treatment. The improved control of septic peritonitis in C48/80-pretreated diabetic mice could not be attributed to glucose metabolism effects, as the drug did not alter hyperglycemia. C48/80 pretreatment was previously demonstrated to prevent neutrophil migration impairment and systemic mediator release after SS (23) . A different study showed that, after MC stabilization using cromolyn sodium, mice were protected from a lethal dose of i.v. Gram-negative bacteria (48) . Overall, our results implicate MCs in both neutrophil migration impairment and systemic inflammatory mediator release in response to septic stimulus in diabetic mice. Chemokines and their receptors play a pivotal role in regulating the activation and migration of leukocytes through the extracellular matrix (49) . The importance of CXC-ELR + chemokines and their receptors for host defense against infection has been demonstrated in various models (50, 51) . In humans (52) and experimental sepsis (13) , reduced neutrophil chemotaxis and migration were associated with decreased CXCR2 expression on circulating neutrophils. Similarly, we found that CXCR2 expression in neutrophils was significantly reduced during MS in diabetic mice, but C48/80 pretreatment prevented this receptor internalization. The decline in CXCR2 expression on circulating neutrophils from septic mice correlated with an upregulation of GRK2 expression, which phosphorylates G protein-coupled receptors to signal receptor desensitization (53) . In addition, we verified that C48/80 administered before SS inhibited GRK2 induction and increased survival rates. These data suggest that MC degranulation contributes to neutrophil migration failure through a mechanism dependent on intracellular GRK2 expression during SS. In addition, we found that blood neutrophils from diabetic mice undergoing MS expressed high levels of intracellular GRK2, but this expression was diminished after C48/80 pretreatment. Our findings also indicate that the neutrophil migration failure induced by MC degranulation in diabetic mice is dependent on decreased CXCR2 expression mediated by increased intracellular GRK2.
Because we found a large number of MCs in the peritoneal cavity of diabetic mice, we focused our investigation on determining which factors released by MCs enhance diabetic mouse susceptibility to septic peritonitis. One recent study reported that hyperglycemia may trigger a sequence of events leading to an enhancement of basal histidine decarboxylase activity and elevated histamine production after LPS challenge (34) . Likewise, serum levels of histamine were higher in diabetic mice than in nondiabetic mice after septic peritonitis induction. Our data suggest that the vast majority of serum histamine is derived from preformed MC granules because C48/80 pretreatment drastically reduced systemic histamine release. In parallel, we observed that diabetic mouse mortality after MS declined after treatment with an H 2 antagonist, correlated with neutrophil migration, and re-established CXCR2 expression on these cells. Our research group already reported that the pretreatment with MK886 (LTB 4 synthesis inhibitor) of mice given septic peritonitis induced by CLP reduced the neutrophil migration in the peritoneal cavity and survival rate when compared with untreated mice (54) . In agreement, other studies using mice lacking LTB 4 -specific receptor (BLT-1) (55) or treated with the LTB 4 receptor antagonist (56) confirmed that LTB 4 promotes the neutrophil migration into peritoneal cavity and local chemokine production after CLP. Because histamine causes the inhibition of LTB 4 production via H 2 (30) , and this mediator plays an important role in neutrophil migration and protection to sepsis, we might not exclude that the deleterious effects of histamine are, at least in part, dependent on decreased levels of LTB 4 in this experimental model. Taken together, our results suggest that histamine released by MCs account for neutrophil migration failure and sepsis onset in diabetic mice.
Chemotactic deactivation may be an important mechanism in inhibition of neutrophil chemotaxis in some syndromes characterized by recurrent bacterial infections. Cold urticaria is one such syndrome (57) , where neutrophil chemotactic defects are related to high levels of IgE and histamine in serum (58, 59 ). In addition, functional studies reported that the chemotaxis of neutrophils in normal and atopic subjects is inhibited by histamine, and this inhibition is more evident in atopic individuals. Furthermore, the incubation of neutrophils from these individuals with an H 2 antagonist reversed the inhibitory effect of histamine on neutrophil chemotaxis (60) . On the other hand, increased adhesion molecule expression in endothelial cells is promoted by histamine via H 1 (61, 62) . Histamine regulates the expression of its own receptors on endothelial cells (63) . Thus, histamine can either directly suppress the neutrophil chemotaxis activity via H 2 or indirectly induce neutrophil rolling, adhesion, and transmigration via H 1 acting on endothelial cells. These studies support our finding that the antagonism of H 1 and H 2 did not alter the survival rates in MS diabetic mice; however, blocking only H 2 increased the survival rates.
In additional experiments, we evaluated the in vivo role of histamine in septic peritonitis. Histamine administration to nondiabetic mice impaired neutrophil migration in a CXCR2-dependent manner. To gain further insight regarding the influence of histamine on CXCR2 regulation, we confirmed that histamine reduced neutrophil chemotaxis and promoted the CXCR2 desensitization associated with GRK2 upregulation. A previous study demonstrated that histamine stimulates the random motility (chemokinesis) and inhibits the directional motility (chemotaxis) of neutrophils in vitro. This study also showed that cAMP levels in neutrophils are significantly increased after histamine incubation and decreased after treatment with an H 2 antagonist (64). Complementing these studies, we demonstrated an additional effect of histamine in neutrophil migration by induction of CXCR2 receptor desensitization perhaps via GRK2 upregulation. In support, another study also found that histamine-deficient mice control Escherichia coli infection better than wild-type mice, which was related to high leukocyte migration (43) . Also, importantly, histamine is induced during acute M. tuberculosis infection and may dampen protective immunity by augmenting the inflammatory response associated with this disease (65) .
MCs have been proposed to enhance survival by augmenting intracellular neutrophil killing through either IL-6 production (66) or through the action of MC proteases (67) . In general, our findings support that activation of local MCs is crucial for host defense during bacterial infection because nondiabetic W/W v mice had more sepsis mortality than WB/B6 nondiabetic mice. In contrast, we showed that diabetic W/W v mice had lower sepsis mortality than WB/B6 diabetic mice. In agreement, other studies have shown that systemic MC activation exacerbates mortality during SS (24, 68) . Although MCs may induce neutrophil recruitment and activation, and could have a protective role during acute local infection, these effects can be overcome and ultimately become detrimental during systemic and severe infections. In addition, along with improved survival, diabetic W/W v mice undergoing MS had lower numbers of bacteria in the blood and increased neutrophil migration into the peritoneal cavity that were associated with decreased CXCR2 internalization, indicating that MC deficiency confers resistance to septic peritonitis in diabetic mice.
NOD mice spontaneously develop a form of diabetes that closely resembles the human disease (69) . Accordingly, NOD mice were more susceptible to MS than prediabetic mice, with 50 and 25% mortality rates, respectively. Septic peritonitis was exacerbated in NOD mice when compared with prediabetic mice because these mice were unable to clear the polymicrobial infection, which then progresses to bacteremia. These effects correlated with increased MC numbers, increased serum histamine levels, impaired neutrophil migration, and downregulation of CXCR2 expression on blood neutrophils. H 2 pretreatment of NOD mice promoted neutrophil chemotaxis and migration associated with maintenance of CXCR2 expression and, consequently, a better control of bacterial infection.
In conclusion, this study shows that MC degranulation induces neutrophil migration failure through CXCR2 receptor desensitization by a mechanism that is dependent on augmented GRK2 expression and that ultimately results in sepsis development. In addition, to our knowledge, we provide the first evidence that MCs appear to exert these harmful effects through the systemic release of histamine. Taken together, our results suggest that inhibition of histamine-mediated signaling through H 2 antagonism might confer protection against sepsis onset in a diabetic host.
